
|Articles|March 19, 2019
EVERSANA Unveils Global Market Access Research Solution
Advertisement
EVERSANA-independent provider of global services for the life sciences industry-released Global Market Access Insights, a new suite of global market access solutions from Health Strategies Insights for biopharma manufacturers. The suite helps manufacturers understand the latest global trends in access, payment, distribution, and administration.
Global Market Access Insights includes:
- Frameworks and proprietary methods.
- Access to a panel of industry experts.
- Address payer stakeholders’ challenges through Global Access Express, which deploys custom research studies to EU5 stakeholders and returns insights within 10 business days.
- Insights on the impact of Evolution of the Global Biosimilars Market and how these blockbuster therapies are evolving in key geographies, including the U.S.
- U.S. Knowledge for Global Market Access to help inform global market access strategies.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
2
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
3
FDA Announces New Biosimilar-Targeted Draft Guidance
4
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
5





